Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke

Neuroradiology

Volumn 46, Issue 11, 2004, Pages 883-887

  Derex, Laurent ^a,c   Hermier, M ^a,c   Adeleine, P ^b   Pialat, J B ^c   Wiart, M ^c   Berthezene Y ^c   Froment, J C ^a   Trouillas, P ^a   Nighoghossian, N ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Acute stroke; MRI; Perfusion weighted imaging; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ANTERIOR CEREBRAL ARTERY; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODYNAMIC PARAMETERS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; RECANALIZATION; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 11244271413     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1279-y     Document Type: Article

References (18)

1. PD Schellinger JB Fiebach O Jansen PA Ringleb A Mohr T Steiner S Heiland S Schwab O Pohlers H Ryssel B Orakcioglu K Sartor W Hacke 2001 Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia Ann Neurol 49 460 469 10.1002/ana.95.abs 1:STN:280:DC%2BD3M3hvVyluw%3D%3D 11310623
2. Linfante I, Llinas RH, Selim M, Chaves C, Kumar S, Parker RA, Caplan LR, Schlaug G (2002) Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33:2066-2071. 10.1161/01.STR.0000021001.18101.A5 12154264
3. RötHer J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-HülSing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W, Kompetenznetzwerk Schlaganfall Study Group (2002) Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 33:2438-2445 10.1161/01.STR.0000030109.12281.23 12364735
4. Brott TG, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M (1989) Measurements of acute cerebral infarction. A clinical examination scale. Stroke 20:864-870. 1:STN:280:BiaA3MfjvFw%3D 2749846
5. Neumann-Haefelin T, Wittsack HJ, Fink GR, Wenserski F, Li TQ, Seitz RJ, Siebler M, MödDer U, Freund HJ (2000) Diffusion- and perfusion-weighted MRI. Influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. Stroke 31:1311-1317. 1:STN:280:DC%2BD3c3pslSrtw%3D%3D 10835450
6. Nighoghossian N, Hermier M, Adeleine P, Derex L, Dugor JF, Philippeau F, Ylmaz H, Honnorat J, Dardel JP, Berthezàne Y, Froment JC, Trouillas P (2003) Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 34:458-463. 10.1161/01.STR.0000053850.64877.AF 1:STN:280:DC%2BD3s%2FmsVClug%3D%3D 12574560
7. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996a) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part I: Mathematical approach and statistical analysis. Magn Reson Med 36:715-725. 1:STN:280:ByiD2szislA%3D 8916022
8. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR (1996b) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part II: Experimental comparison and preliminary results. Magn Reson Med 36:726-736. 1:STN:280:ByiD2szislE%3D 8916023
9. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME (1999) Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 52:1792-1798. 1:CAS:528:DyaK1MXktVeju7g%3D 10371525
10. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, Van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607
11. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthezàne Y, Ffrench P, Dechavanne M (1998) Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke. Determination of etiological, topographic and radiological outcome factors. Stroke 29: 2529-2540. 1:STN:280:DyaK1M%2FlsFKhuw%3D%3D 9836764
12. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
13. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Oshumi Y, Kitano K, Tutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976-982. 1:STN:280:By2B2MzgsFU%3D 1579252
14. Del Zoppo G, Poeck K, Pessin M, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldman E, Hacke W, Higashida RT, Gent M, Rowley H, Ahuja A, Callahan F, Clark WM, Kase C, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic or embolic stroke. Ann Neurol 32:78-86
15. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G (1998) Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 29:939-943. 1:STN:280:DyaK1c3lsFKkug%3D%3D 9596239
16. Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Jolley D, Donnan GA, Tress BM (1999) Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 52:1125-1132. 1:STN:280:DyaK1M3ivFGntw%3D%3D 10214732
17. Sorensen AG, Copen WA, Ostergaard L, Buonanno FS, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ (1999) Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow and mean transit time. Radiology 210:519-527. 1:STN:280:DyaK1M3itlyntA%3D%3D 10207439
18. Grandin CB, Duprez TP, Smith AM, Oppenheim C, Peeters A, Robert AR, Cosnard G (2002) Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 223:361-370